BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/10/2018 8:42:53 AM | Browse: 792 | Download: 1246
 |
Received |
|
2018-05-07 00:33 |
|
Peer-Review Started |
|
2018-05-07 01:51 |
|
To Make the First Decision |
|
2018-05-24 23:53 |
|
Return for Revision |
|
2018-05-25 07:45 |
|
Revised |
|
2018-08-05 19:04 |
|
Second Decision |
|
2018-08-30 08:02 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-08-30 17:43 |
|
Articles in Press |
|
2018-08-30 17:43 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-09-09 01:40 |
|
Typeset the Manuscript |
|
2018-10-10 01:51 |
|
Publish the Manuscript Online |
|
2018-10-10 08:42 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Minireviews |
| Article Title |
Oral alkali therapy and the management of metabolic acidosis of chronic kidney disease: a narrative literature review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Adeel Rafi Ahmed and David Lappin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Adeel Rafi Ahmed, MBChB, MRCP, Staff Physician, Department of Nephrology, University Hospital Galway, Newcastle Road, Galway H91YR1, Ireland. adeel.r.ahmed@gmail.com |
| Key Words |
Chronic metabolic acidosis; Chronic kidney disease; Oral sodium bicarbonate; Oral alkali therapy; Health economics; Serum bicarbonate |
| Core Tip |
Chronic metabolic acidosis contributes to the progression of chronic kidney disease (CKD). We summarise and analyse current evidence regarding the management of the metabolic acidosis of CKD, as well as the potential benefits and adverse effects. We also offer novel therapeutic guidelines for clinicians, which include the most evidence-based range to maintain serum bicarbonate in the CKD patient population. |
| Publish Date |
2018-10-10 08:42 |
| Citation |
Ahmed AR, Lappin D. Oral alkali therapy and the management of metabolic acidosis of chronic kidney disease: A narrative literature review. World J Nephrol 2018; 7(6): 117-122 |
| URL |
http://www.wjgnet.com/2220-6124/full/v7/i6/117.htm |
| DOI |
http://dx.doi.org/10.5527/wjn.v7.i6.117 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
